摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propylamino]hexyl nitrate | 1011297-25-8

中文名称
——
中文别名
——
英文名称
6-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propylamino]hexyl nitrate
英文别名
——
6-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propylamino]hexyl nitrate化学式
CAS
1011297-25-8
化学式
C22H32N4O3
mdl
——
分子量
400.521
InChiKey
KDYGCIXCFTVKNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    29
  • 可旋转键数:
    12
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    92
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    6-bromohexyl nitrateN-(1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diaminepotassium carbonate 作用下, 以 二氯甲烷 为溶剂, 反应 36.0h, 以34%的产率得到6-[3-(1,2,3,4-Tetrahydroacridin-9-ylamino)propylamino]hexyl nitrate
    参考文献:
    名称:
    Synthesis and Biological Evaluation of NO-Donor-Tacrine Hybrids as Hepatoprotective Anti-Alzheimer Drug Candidates
    摘要:
    In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1-14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects. Compounds 1-13 showed good cholinesterases inhibitory activities in vitro, while 14, particularly, was highly selective, preferring butyrylcholinesterase rather than acetylcholinesterase. Four selected compounds (1, 9, 11, and 14) moderately relaxed the porcine pulmonary arteries in organ bath. In the hepatotoxicity study, significant hepatotoxicity was caused by tacrine but not by 9.
    DOI:
    10.1021/jm701491k
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of NO-Donor-Tacrine Hybrids as Hepatoprotective Anti-Alzheimer Drug Candidates
    作者:Lei Fang、Dorothea Appenroth、Michael Decker、Michael Kiehntopf、Carolin Roegler、Thomas Deufel、Christian Fleck、Sixun Peng、Yihua Zhang、Jochen Lehmann
    DOI:10.1021/jm701491k
    日期:2008.2.1
    In search of safer anti-Alzheimer drugs, 14 NO-donor-tacrine hybrids (1-14) were synthesized and evaluated for their ability to inhibit cholinesterases and for vasorelaxation effects. Compounds 1-13 showed good cholinesterases inhibitory activities in vitro, while 14, particularly, was highly selective, preferring butyrylcholinesterase rather than acetylcholinesterase. Four selected compounds (1, 9, 11, and 14) moderately relaxed the porcine pulmonary arteries in organ bath. In the hepatotoxicity study, significant hepatotoxicity was caused by tacrine but not by 9.
查看更多